Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(29%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_2

43%

Ph phase_4

14%

Ph not_applicable

14%

Ph phase_3

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

3(42.9%)

Phase 3Large-scale testing

2(28.6%)

Phase 4Post-market surveillance

1(14.3%)

N/ANon-phased studies

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(2)

Detailed Status

Not yet recruiting3

Active, not recruiting2

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 23 (42.9%)

Phase 32 (28.6%)

Phase 41 (14.3%)

N/A1 (14.3%)

Trials by Status

active_not_recruiting229%

completed229%

not_yet_recruiting343%

Recent Activity

2 active trials

Showing 5 of 7

completedphase_2

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

NCT02966873

not_yet_recruitingphase_4

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine

NCT07273071

not_yet_recruitingphase_3

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

NCT06956482

active_not_recruitingphase_2

N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy

NCT07279610

not_yet_recruitingphase_3

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

NCT07136987

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT02966873Phase 2

Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)

Completed

NCT07273071Phase 4

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine

Not Yet Recruiting

NCT06956482Phase 3

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

Not Yet Recruiting

NCT07279610Phase 2

N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy

Active Not Recruiting

NCT07136987Phase 3

A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery

Not Yet Recruiting

NCT07093944Phase 2

Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study

Completed

NCT06872372Not Applicable

Role of N-Acetylcysteine in Non-Acetaminophen-Induced Acute Liver Failure

Active Not Recruiting

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7